MedPath

Study on Prevention of Gastric Cancer by Early Detection of Helicobacter pylori Infection and Its Eradication(2nd-Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health and Welfare of Japan)

Not Applicable
Conditions
Gastritis
Registration Number
JPRN-C000000191
Lead Sponsor
Second-Term Comprehensive 10-Years Strategy for Cancer Control (Ministry of Health and Welfare of Japan):Cancer Prevention
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
750
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients who suffer from acuteulcer(AGML, etc,) and gastrointestinal ulcer (stage A1-S2) 2)Patients who suffer from pyloric stenosis, perforation, profuse hemorrhage, etc, and indications of surgical therapy 3)Patients with the anamnesis of gastrectomy or vagotomy 4)Patients with gastric adenoma or active malignant tumor in the stomach and other organs 5)Patients with severe complications (cardiac diseases, hepatic diseases, renal diseases, hematological diseases, etc.) 6)Patients who are the continuous users of possibly ulcerogenic drugs (for instance, steroids, non-steroids, salicylates, etc.) 7)Patients who are or may be pregnant, who are lactating and who wish to become pregnant before and after eradication treatment 8)Patients who have the anamnesis of hypersensitivity to antibiotics, proton pump inhibitors, or other drugs which will be used in the present study 9)Patients who have been judged by the physician in charge to be inappropriate as subjects from other reasons

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath